Kim Sablich
Overview
Kim Sablich received $5M in total compensation, including $328K in salary, at Jazz Pharmaceuticals in 2020. Kim Sablich also received $2M at Myovant Sciences Ltd. in 2018.
Source: SEC filings on June 11, 2021 and July 25, 2019.
Related executives
We found 29 more executives who work or worked at Jazz Pharmaceuticals and Myovant Sciences Ltd..
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
David Marek
Myovant Sciences Ltd.
Principal Executive Officer
Daniel Swisher
Jazz Pharmaceuticals
President
Uneek Mehra
Myovant Sciences Ltd.
Principal Financial Officer
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
Frank Karbe
Myovant Sciences Ltd.
Former Principal Financial and Accounting Officer
Chris Tovey
Jazz Pharmaceuticals
Chief Operating Officer
Robert MSCE
Jazz Pharmaceuticals